HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

199 - Axe the Anaerobes, Drop the Docuste, Free the Fluids

In this episode, we review three medical myths, highlighted in the "Things We Do For No Reason" series of the Journal of Hospital Medicine, including anaerobic coverage f

198 - Lp(a), ApoB, and CAC: Navigating the 2026 Dyslipidemia Guideline Alphabet Soup

In this episode, we review key updates from the 2026 ACC-AHA Guidelines on the Management of Dyslipidemia. Key Concepts The PREVENT ASCVD equation is now recommended

197 - Sweet Deal of Updates in Diabetes Pharmacotherapy from the ADA 2026 Standards of Care

In this episode, we discuss the most important annual updates in the American Diabetes Association Guidelines, Standards of Care 2026, particularly focusing on changes in

196 - Stretching the Stroke Clock to 2026: A Brief Review of the 2026 Acute Ischemic Stroke Guidelines

In this episode, we review key updates from the 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke, including changes to IV thrombolys

195 - Burning Questions about Uncomplicated UTI Diagnosis and Treatment

In this episode, we review the clinical presentation, diagnosis, and treatment of uncomplicated urinary tract infections. Key Concepts Uncomplicated urinary tract inf

194 - 5-HT3 Receptor Antagonists for Nausea/Vomiting: An In-Depth Drug Class Review

In this episode, we review the pharmacology, indications, adverse effects, and unique drug characteristics of 5-HT3 receptor antagonists such as ondansetron (Zofran) and

193 - Elevate Your Guideline Knowledge, Not Your BP: The New 2025 Hypertension Guidelines

In this episode, we review the newly published 2025 ACC/AHA hypertension guidelines. Key Concepts Instead of the Pooled Cohort Equations (PCE) from 2013, the 2025 hyp

192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative

In this episode, we discuss the evidence, safety, and place in therapy of Journavx® (suzetrigine), a newly approved analgesic with a unique non-opioid mechanism of action

191 - The Ultimate Guide to ARBs: An In-depth Drug Class Review

In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of angiotensin receptor blockers (ARBs).  Key Con

190 - Can't Stop, Won't Drop … The BP That Just Won't Quit: Diagnosis and Treatment of Resistant Hypertension

In this episode, we discuss the diagnosis and treatment of resistant hypertension, including a newer endothelin receptor antagonist (ERA) called aprocitentan (Tryvio®).

189 - Mice, Macrophages, and Metabolism: Browning Keeps Obesity at Bay

In this episode, we discuss the very early stages of drug targets and drug development with Dr. Mohd Shahid, PhD. Dr. Shahid's research involves the IER3 gene, which is a

188 - The Clot Thickens: Key Updates from the 2025 Acute Coronary Syndromes Guidelines

In this episode, we review the new 2025 ACC/AHA Acute Coronary Syndrome (ACS) guidelines, with a particular focus on guideline recommendations for analgesics, P2Y12 inhib

187 - Infectious Ambitions: A Pharmacist's Career Pivot from Clinical to Industry

In this episode, we interview Morgan Anderson, PharmD, BCIDP, a graduate of the RFUMS College of Pharmacy, about her career path from a pharmacy resident, emergency medic

186 - Breaking the Bank or Breaking the Scale: Controversies Surrounding Compounded GLP-1s RAs for Weight Loss

In this episode, we discuss the efficacy and safety of semaglutide and tirzepatide for weight loss with a particular focus on the legal, regulatory, and safety aspects of

185 - They Are Late, but Don't Stress: The New 2024 Stress Ulcer Prophylaxis Guidelines

In this episode, we review the recommendations from the 2024 SCCM/ASHP stress ulcer prophylaxis guidelines and highlight three of the more recent landmark critical care t

184 - Drop it Like it's Hot! Deprescribing Pharmacotherapy When Appropriate

In this episode, we discuss the approach to deprescribing for several drugs such as benzodiazepine receptor agonists, cholinesterase inhibitors, memantine, antipsychotics

183 - The Ultimate Guide to Loop Diuretics: An In-Depth Drug Class Review

In this episode, we review the pharmacology, pharmacokinetics, adverse effects, monitoring, medicinal chemistry, and more of loop diuretics. Key Concepts Loop diureti

182 - 2023 Beers Criteria Update: Navigating Medications Safely in Older Patients

In this episode, we discuss principles for medication use in the geriatric patient population and summarize the updated 2023 American Geriatrics Society Beers Criteria fo

181 - From Meds to Machine Learning: How AI is (and will) Revolutionizing Pharmacy Practice

In this episode, we discuss artificial intelligence large language models (LLMs) and how these will impact the future of the practice of pharmacy. Key Concepts Genera

180 - The Ultimate Guide to Statins: An In-Depth Drug Class Review

In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of HMG CoA reductase inhibitors ("statins"). Key